Agios Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Agios Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Agios Pharmaceuticals Inc
Rating: 0.99727775
Author: Trendlyne DVM scores

Momentum Trap

about

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially tra...

28.68 -0.09 (-0.31%)

37.65% Fall from 52W High

271.3K

XNAS Volume

XNAS 14 May, 2026 2:26 PM (EDT)

Board Meeting

The next board meeting for Agios Pharma Inc is on 19 May 2026 for the purpose of RBC Capital Markets 2026 Global Healthcare Conference See details

Low Financial Strength

11.1 / 100

Expensive Valuation

19.0 / 100

Technically Neutral

38.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 43%

8 analysts

Agios Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Agios Pharma Inc Live Stock Price Today, Share Analysis and Chart

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially tra...

37.65% Fall from 52W High

SWOT Analysis

Agios Pharma Inc Live Price Chart